Studies on macromolecular synthesis have taken advantage of both in vivo and in vitro systems. However, in vivo studies have often been hindered by the fact that most cells are not permeable to charged moelcules. In many cases this difficulty has been overcome by making cells permeable with different chemical agents even if these treatments result in death of the cells. Permeabilization of bacterial cells has recently been attained with several organic solvents. For example, bacteria treated with toluene have successfully :been used in studies of deoxyribonucleic acid (DNA) replication (12, 15) and repair (15) and of ribonucleic acid (RNA) synthesis (16) . So far such systems have not been extensively developed for eukaryotic cells, where it has been shown that isolated cell nuclei (5, 40, 21) and cellular ghosts containing nuclei (20) are very useful tools for studying transcription and maturation of specific RNA species.
We have developed a permeabilization procedure for yeast cells that allows study of macromolecular syntheses in a system that has retained sbme physiological properties. We have observed that cells of Kluyveromyces lactis treated with nystatin, a polyene antibiotic that is believed to alter the membrane structure (8), become permeable not only to some antibiotics but also to ribo-and deoxynucleoside triphosphates. We have shown that nystatin-treated cells are able to support RNA synthesis dependent on exogenous triphosphates. MATERIALS The powder was dissolved at 1 mg/ml in 50% dimethylformamide. Phenylmethylsulfonylfluoride was purchased from Sigma Chemical Co., St. Louis, Mo., and dissolved in ethanol before use. Alphaamanitin was purchased from Boehringer Corp., Ingelheim, Germany, dissolved in distilled water, and stored at -20 C.
Treatment of K. lactis cells with nystatin. K. lactis cells, strain 2359 CBS prototroph, were grown at 30 C in a medium containing 0.5% yeast autolysate (Costantino Corp., Torino, Italy), 1% bacteriological peptone (Oxoid Division, Oxo Ltd., London, England), and 1% glucose (YEDP medium) to a density of 108 to 2 x 108 cells/ml. Nystatin (10 ,mg/ml) was then added, and growth continued for 30 min unless otherwise stated. Cells were harvested by centrifugation at 2,000 rpm at 4 C for 10 min, resuspended by gentle shaking in 1/10 volume of 50 mM Tris-hydrochloride (pH 7.9)-0.1 mM dithioerithritol, and centrifuged for 10 min at 2,000 rpm at 4 C. The pellet was resuspended in 10 mM Tris-hydrochloride, pH 7.9, at a density of 1010 cells/ml and immediately used in the assay. Cells treated with nystatin were tested for survival, as measured by ability to form colonies on plates of YEDP medium containing 2% agar. Cells treated for 20 min with 10 ,ug of nystatin per ml exhibited a survival of 10-7. Assay for RNA synthesis. Syntheis of RNA in nystatin-treated cells was followed by measuring the incorporation of [3H]UTP into trichloroacetic acid-insoluble material.
The standard mixture (230 ul) contained: 50 mM 748
Tris-hydrochloride, pH 7.9 at 20 C; 3 mM MnCl2; 6 mM MgCl2; 200 mM ammonium sulfate; 0.1 mM dithioerithritol; 1 mM each adenosine 5'-triphosphate (ATP), guanosine 5'-triphosphate, and cytidine 5'-triphosphate; and 0.025 mM [2H]UTP (200 counts/min per pmol). Unless otherwise stated, the assay contained 109 nystatin-treated cells. Incubation was at 30 C for 10 min. The reaction was terminated by the addition of 1 ml of cold 10% trichloroacetic acid. Samples were kept on ice 45 min before being filtered on glass fiber filters (Whatman GF/C). Radioactivity was determined by scintillation counting.
RNA extraction. A 2.3-ml amount of standard incubation mixture for RNA synthesis, containing 1010 nystatin-treated cells, was incubated at 30 C for 10 min. The reaction was terminated by chilling and addition of 0.1 M EDTA and 4% Sarkosyl (final concentrations). To disrupt cells, the sample was incubated in boiling water for 3 min and immediately chilled. Water-saturated phenol was added to the sample and shaken for 15 min at room temperature. The aqueous phase was removed and centrifuged to clarity, and the extraction was repeated. The aqueous phase was then dialyzed against 1 M NaCl for 4 h. RNA was precipitated by addition of 2 volumes of 95% ethanol. The precipitate was dissolved in 0.1 M sodium phosphate buffer (pH 7.7)-1.1 M formaldehyde, incubated at 65 C for 10 min, and analyzed by centrifugation on a sucrose density gra-
Sedimentation analysis of RNA. The 3H-labeled RNA (20,000 counts/min total), extracted and treated as described above, was layered onto a 5 to 20% (wt/vol) linear sucrose gradient in 0.1 M sodium phosphate (pH 7.7) and 1.1 M formaldehyde and centrifuged for 4 h at 43,000 rpm at 23 C in a Spinco SW50 rotor. Fractions of 120 pl were collected on Whatman GF/C filters and processed according to Bollum (4) . Radioactivity was determined by scintillation counting. Purified rat liver ribosomal RNAs (5S, 18S, and 28S) were used as sedimentation markers.
RESULTS
RNA synthesis dependent on exogenous nucleoside triphosphates was induced in K. lactis cells by pretreatment with nystatin ( Fig. 1 ). The capacity of K. lactis cells to sustain RNA synthesis increased with the time of preincubation with nystatin for about 2 h and then leveled off.
RNA synthesis in nystatin-treated cells required the presence of divalent ions. Mg2+ and Mn2+ were almost equally effective (Fig. 2) ; Mn2+ was more efficient at low concentrations (optimum at 3 mM) whereas Mg2+ stimulated over a broad range of concentrations. This is similar to what has been observed with purified RNA polymerases, although the multiple forms of RNA polymerase purified from K. lactis are not equally stimulated by these ions (17 DNA. To insure that in our system the majority of the RNA polymerase activity was detectable we studied the rate of synthesis in the presence of both ions. In the presence of 6 mM Mg2+ the addition of 1 mM Mn2+ produced a slight stimulation, whereas higher doses of Mn2+ reduced the synthesis. Similarly, the addition of Mg2+ to 3 mM Mn2+ produced a slight stimulation only at low doses (Fig. 3) .
The addition of ammonium sulfate markedly stimulated RNA synthesis, but the dependence on the concentration of this salt was bimodal, with maxima at 80 and at 300 mM (Fig. 4) . This bimodal curve may have resulted from the sum of the activities of RNA polymerases IA, IB, and II, which have an optimum at 0.1 M ammonium sulfate, and of the activity of RNA polym- [5 -_0_ the system of either DNA or DNase I (10 jig/ml) had no effect on the reaction. As expected, RNA synthesis was completely inhibited by 10 ,ug of pancreatic ribonuclease per ml added at zero time of the reaction.
Sarkosyl, a detergent known to stimulate synthesis of RNA in mouse nuclei (6) , had an inhibitory effect on this system. At 0.1 ,ug/ml the reaction was 50% inhibited. However, the residual activity was not suppressed even by a concentration of Sarkosyl 10 times higher.
The kinetics of incorporation of labeled UTP into RNA was not linear at early times ( The extent of the reaction was directly proportional to the concentration of the cell suspension, from 107 to 10" cells per assay (data not shown).
The reaction was 80 to 90% inhibited at 10 ,ug of actinomycin D per ml, but 0.1 ,ug of the same drug per ml gave about 50% inhibition (Fig. 6) . No inhibition was observed with the following drugs: rifampin (100 ug/ml); rifamycin SV-AF/ 013 (100 ,tg/ml); streptolydigin (400 ,mg/ml); lipiarmycin (400 ,ug/ml); and a-amanitin (100 ,ug/ ml). However, it should be noticed that when rifampin and rifamycin SV-AF/013 were used at a concentration of 400 ,ug/ml, a reduction of 20 and 50%, respectively, was observed in RNA synthesis. The inhibition obtained at high doses of drug was probably not caused by specific action on transcription, but rather by a change in the properties of the assay solution due to the high concentration of hydrophobic chemicals (18) . It is worth noting that K. lactis growth in YEDP medium was not inhibited by rifampin, rifamycin SV-AF/013, lipiarmycin, or streptolydigin at 400 ,ug/ml, nor by a-amanitin or actinomycin D at 50 ,ug/ml.
Characterization of the RNA product. The acid-insoluble radioactive material synthesized by nystatin-treated cells was completely digested to acid solubility by treatment with 0.4 N NaOH for 4 h at 37 C.
The RNA was also analyzed by sedimentation on sucrose gradients in the presence of formaldehyde to avoid aggregation and interaction of RNA with DNA fragments. The bulk of the RNA sedimented at about 5S in 1.1 M formaldehyde, which corresponds to an RNA with a molecular weight of 100,000. However, RNA sedimenting at 8S, which corresponds to a molecular weight of 320,000, was also present, although in a minor amount (Fig. 7) .
During the course ofRNA synthesis in nystatin-treated cells no acid-insoluble counts were released in the supernatant, as shown by the fact that after centrifugation for 10 min at 2,000 rpm all the acid-insoluble radioactivity was found in the pellet. This result indicates that RNA synthesis occurs inside the cells (11) .
However, if the cells were centrifuged for 10 min at 10,000 rpm, 50% of the RNA was released in the supernatant. This suggests that rough treatment of the nystatin-treated cells may damage the cell structure and release cytoplasmic components. DISCUSSION The polyene antibiotics nystatin and amphotericin B have been successfully used, at sublethal doses, to permeabilize yeasts (13, 17) and other eukaryotic cells (1, 7, 9, 14) towards small molecules and some inhibitors of macromolecular synthesis. The inhibitory synergism of amphotericin B with rifampin observed on Saccharomyces cerevisiae growth and RNA synthesis in vivo (2, 13) has also been observed with the combination of nystatin and rifampin or streptolydigin on K. lactis (17) . The inhibition of RNA synthesis is probably not caused by a direct effect of rifampin or streptolydigin on transcription itself since the RNA polymerases purified from K. lactis are not susceptible to any of these antibiotics (17) . This conclusion is strengthened by the finding that RNA synthesis in nystatin-permeabilized cells is not inhibited by rifampin or streptolydigin. Although nystatin-treated cells are no longer viable, they still retain some physiological features. RNA synthesis is associated with the cell and probably occurs inside the cell, it is inhibited by actinomycin D, and it is dependent on all four ribonucleoside triphosphates. Thus the system is not dependent on the nucleotide pools of the cells and on membrane transport of RNA precursors. Even though the results obtained with this system do not rule out definitively a direct effect of rifampin on transcription machinery of the cell, we propose that the synergistic effect of nystatin in combination with rifampin, observed in vivo, may concern cell permeability of RNA precursors rather than transcription.
A survey of results observed with various inhibitors of RNA synthesis tested in various systems on K. lactis is shown in Table 2 . It may be seen that actinomycin D, which had no effect on RNA synthesis in vivo, was active on nystatin-treated cells and on purified RNA polymerases. It is difficult to explain the lack of inhibition of RNA synthesis by a-amanitin in nystatin-treated cells. It was probably not due to a lack of permeability of treated cells towards this drug, since nystatin-treated cells are permeable to much larger molecules like actinomycin D or pancreatic ribonuclease. It is known that a-amanitin inhibits the activity of RNA polymerase II only, the enzyme believed to be capable of nucleoplasmic RNA synthesis. The sedimentation analysis of the RNA synthesized by nystatin-treated cells showed that no RNA with a sedimentation coefficient greater than 10S in 1.1 M formaldehyde, which would Experiments in progress have shown that nystatin-treated cells are also capable of sustaining DNA synthesis dependent on exogenous deoxyribonucleoside triphosphates and on exogenous ATP, suggesting that this system may also furnish a new tool for studies of DNA replication and repair in yeast cells.
